Want to see IN:KINGFA full AI Analyst Report?
Top Page
Kingfa Science & Technology (India) Limited
(KINGFA)
Select Model
Select Model
Rating:73Outperform
Price Target:
₹6,081.00
▲(28.59% Upside)
Action:Upgraded
Date:06/01/26
The score is driven primarily by strong fundamentals (growth and low leverage), supported by bullish technical trend signals. This is tempered by weaker cash-flow conversion and a high P/E valuation that raises execution expectations.
Positive Factors
Sustained Revenue Scaling
Multi-year revenue expansion to ~20B by 2026 reflects durable demand across automotive, electrical and industrial end-markets. Scale supports pricing leverage, product qualification cycles that drive recurring volumes, and stronger negotiating power with suppliers over the medium term.
Negative Factors
Weak Free Cash Flow Conversion
Negative and volatile free cash flow despite rising accounting earnings suggests working‑capital swings or heavy reinvestment. This undermines internal funding for capex, dividends or buybacks, and increases reliance on external financing for strategic initiatives over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained Revenue Scaling
Multi-year revenue expansion to ~20B by 2026 reflects durable demand across automotive, electrical and industrial end-markets. Scale supports pricing leverage, product qualification cycles that drive recurring volumes, and stronger negotiating power with suppliers over the medium term.
Read all positive factors
Kingfa Science & Technology (India) Limited (KINGFA) vs. iShares MSCI India ETF (INDA)
Market Cap
₹69.67B
Dividend Yield0.24%
Average Volume (3M)305.00
Price to Earnings (P/E)36.4
Beta (1Y)0.98
Revenue Growth14.38%
EPS Growth11.08%
CountryIN
Employees257
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)126.40
Shares Outstanding13,551,381
10 Day Avg. Volume247
30 Day Avg. Volume305
Financial Highlights & Ratios
PEG Ratio2.07
Price to Book (P/B)3.89
Price to Sales (P/S)2.72
P/FCF Ratio-124.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Kingfa Science & Technology (India) Limited Business Overview & Revenue Model
Company Description
Kingfa Science & Technology (India) Limited, headquartered in Chennai, India, is a prominent manufacturer and supplier of advanced polymer solutions within the country. The company specializes in producing reinforced polypropylene compounds and fi...
How the Company Makes Money
KINGFA primarily makes money by selling polymer materials—especially engineered/modified polymer compounds—produced by compounding and formulation (i.e., blending base resins with additives, fillers, reinforcements, and colorants to achieve requir...
Kingfa Science & Technology (India) Limited Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
90
Very Positive
Cash Flow
56
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.38B | 19.96B | 17.45B | 14.87B | 14.04B | 10.48B |
| Gross Profit | 3.86B | 4.01B | 3.36B | 2.37B | 2.86B | 1.63B |
| EBITDA | 2.43B | 2.75B | 2.34B | 1.87B | 1.30B | 595.97M |
| Net Income | 1.57B | 1.85B | 1.53B | 1.23B | 814.10M | 306.33M |
Balance Sheet | ||||||
| Total Assets | 17.35B | 17.54B | 11.56B | 9.94B | 10.10B | 8.77B |
| Cash, Cash Equivalents and Short-Term Investments | 3.90B | 4.45B | 236.63M | 51.12M | 242.14M | 294.17M |
| Total Debt | 316.55M | 154.04M | 430.02M | 325.46M | 424.32M | 460.58M |
| Total Liabilities | 4.40B | 3.54B | 4.26B | 4.06B | 5.44B | 4.92B |
| Stockholders Equity | 12.95B | 13.99B | 7.29B | 5.89B | 4.66B | 3.85B |
Cash Flow | ||||||
| Free Cash Flow | 416.01M | -436.42M | 227.34M | -47.84M | 27.04M | 193.31M |
| Operating Cash Flow | 1.09B | 676.49M | 530.63M | 161.02M | 272.39M | 382.42M |
| Investing Cash Flow | -4.22B | -3.96B | -302.44M | 19.22M | -241.56M | -181.31M |
| Financing Cash Flow | 4.59B | 4.41B | 2.66M | -83.29M | -210.00M | -152.65M |
Kingfa Science & Technology (India) Limited Technical Analysis
Positive
4729.00
Price Trends
5115.05
Negative
4689.28
Positive
4505.45
Positive
Market Momentum
-10.17
Positive
49.13
Neutral
59.31
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KINGFA, the sentiment is Positive. The current price of 4729 is below the 20-day moving average (MA) of 5132.39, below the 50-day MA of 5115.05, and above the 200-day MA of 4505.45, indicating a neutral trend. The MACD of -10.17 indicates Positive momentum. The RSI at 49.13 is Neutral, neither overbought nor oversold. The STOCH value of 59.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:KINGFA.
Kingfa Science & Technology (India) Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹69.67B | 36.43 | ― | 0.24% | 14.38% | 11.08% | |
67 Neutral | ₹137.24B | 30.37 | ― | 0.48% | -0.95% | 9.51% | |
64 Neutral | ₹159.47B | 38.74 | ― | 0.26% | 4.43% | 1.60% | |
59 Neutral | ₹180.60B | 82.92 | ― | ― | 37.53% | 38.70% | |
57 Neutral | ₹144.52B | 84.41 | ― | 0.06% | 64.44% | 77.60% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
45 Neutral | ₹176.85B | 41.66 | ― | 0.26% | 14.15% | 26.69% |
* General Sector Average
IN:KINGFA
Kingfa Science & Technology (India) Limited
5,140.90
1,502.55
41.30%
IN:AARTIIND
AARTI Industries Ltd
487.55
22.09
4.75%
IN:AETHER
Aether Industries Ltd.
1,360.80
567.85
71.61%
IN:ANURAS
Anupam Rasayan India Ltd.
1,269.40
147.58
13.16%
IN:FINEORG
Fine Organic Industries Ltd.
5,201.30
-7.32
-0.14%
IN:VINATIORGA
Vinati Organics Limited
1,323.90
-688.68
-34.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.